Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation
暂无分享,去创建一个
Hong Qing | Zhenzhen Quan | Talal Jamil Qazi | Asif Mir | Zhenzhen Quan | H. Qing | A. Mir | T. J. Qazi | Asif Mir
[1] H. Pollard. The Developing Genome: An Introduction to Behavioral Epigenetics , 2018, Psychiatry.
[2] Xiaowei Chen,et al. Transcriptional Selectivity of Epigenetic Therapy in Cancer. , 2017, Cancer research.
[3] S. Duan,et al. Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males. , 2016, Molecular medicine reports.
[4] D. Bennett,et al. The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism , 2016, Acta Neuropathologica.
[5] Shunichiro Shinagawa,et al. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer’s disease and amnesic mild cognitive impairment patients , 2016, Neuroscience Letters.
[6] B. de Strooper,et al. miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain , 2016, EMBO molecular medicine.
[7] Guowei Huang,et al. Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells , 2016, European Journal of Nutrition.
[8] P. Nelson,et al. Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencing. , 2016, Gene.
[9] P. Jin,et al. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer’s disease , 2016, BMC Genomics.
[10] A. Camozzato,et al. The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer’s disease , 2016, Molecular Biology Reports.
[11] L. Lam,et al. Association of gene expression and methylation of UQCRC1 to the predisposition of Alzheimer's disease in a Chinese population. , 2016, Journal of psychiatric research.
[12] H. Soininen,et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.
[13] Alison I. Bernstein,et al. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. , 2016, Human molecular genetics.
[14] Kenneth H. Pollock,et al. Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International Comparison , 2016, PloS one.
[15] D. Mari,et al. Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease , 2016, Journal of the Neurological Sciences.
[16] M. Barrachina,et al. Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease. , 2016, The American journal of pathology.
[17] A. Sharp,et al. Genome-wide12 DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease , 2016, Genome Medicine.
[18] Shunichiro Shinagawa,et al. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment , 2016, PloS one.
[19] Matthew D. Schultz,et al. Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns , 2016, Translational psychiatry.
[20] T. P. Centeno,et al. DNA methylation changes in plasticity genes accompany the formation and maintenance of memory , 2015, Nature Neuroscience.
[21] J. Sweatt,et al. Tet1 oxidase regulates neuronal gene transcription, active DNA hydroxymethylation, object location memory, and threat recognition memory , 2015, Neuroepigenetics.
[22] S. Leurgans,et al. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. , 2015, The international journal of biochemistry & cell biology.
[23] E. Porcellini,et al. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients , 2015, Neuroscience Letters.
[24] J. Wong,et al. Oxidative DNA demethylation mediated by Tet enzymes , 2015 .
[25] F. Tang,et al. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging , 2015, Science.
[26] Jennifer S. Woo,et al. The cerebellum ages slowly according to the epigenetic clock , 2015, Aging.
[27] J. Sweatt,et al. DNA methylation regulates neurophysiological spatial representation in memory formation , 2015, Neuroepigenetics.
[28] Haiyuan Yu,et al. Trimethylation of Lys36 on H3 restricts gene expression change during aging and impacts life span , 2015, Genes & development.
[29] Daniela Mari,et al. Global changes in DNA methylation in Alzheimer’s disease peripheral blood mononuclear cells , 2015, Brain, Behavior, and Immunity.
[30] D. Moore. The Developing Genome: An Introduction to Behavioral Epigenetics , 2015 .
[31] S. Sorbi,et al. Epigenetic modifications in Alzheimer's disease: cause or effect? , 2014, Journal of Alzheimer's disease : JAD.
[32] J. Jia,et al. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer’s disease , 2014, Acta Neurologica Belgica.
[33] D. Bennett,et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.
[34] Manolis Kellis,et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .
[35] Andre Fischer,et al. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue? , 2014, Neuropharmacology.
[36] Peter D. Adams,et al. Senescent cells harbour features of the cancer epigenome , 2013, Nature Cell Biology.
[37] Stephen Todd,et al. Survival in dementia and predictors of mortality: a review , 2013, International journal of geriatric psychiatry.
[38] T. Hensch,et al. DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease , 2013, Brain : a journal of neurology.
[39] S. Horvath. DNA methylation age of human tissues and cell types , 2013, Genome Biology.
[40] L. Tan,et al. Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy , 2013, Ageing Research Reviews.
[41] G. Andria,et al. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. , 2013, Molecular genetics and metabolism.
[42] Tom H. Cheung,et al. Chromatin Modifications as Determinants of Muscle Stem Cell Quiescence and Chronological Aging , 2013, Cell reports.
[43] Mahsa Jalili. Send Orders of Reprints at Reprints@benthamscience.net Effect of Diet and Nutrients on Molecular Mechanism of Gene Expression Mediated by Nuclear Receptor and Epigenetic Modulation , 2022 .
[44] Elizabeth Head,et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human down syndrome brains. , 2013, The Journal of Biological Chemistry.
[45] T. Ideker,et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.
[46] J. Mill,et al. CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients. , 2012, Journal of Alzheimer's disease : JAD.
[47] H. Manev,et al. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria , 2012, Neurobiology of Aging.
[48] J. Mill,et al. SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer’s Disease , 2012, Neurochemistry International.
[49] Peng Jin,et al. Dynamics of DNA methylation in aging and Alzheimer's disease. , 2012, DNA and cell biology.
[50] J. Mill,et al. Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer’s Disease patients , 2012, Neuroscience.
[51] J. Teng,et al. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1 , 2012, Brain Research Bulletin.
[52] A. Georgakopoulos,et al. Cellular mechanisms of γ-secretase substrate selection, processing and toxicity , 2012, Progress in Neurobiology.
[53] A. Fagan,et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. , 2012, Human molecular genetics.
[54] S. Rapoport,et al. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients , 2012, Translational Psychiatry.
[55] Y. Shi,et al. Tet family proteins and 5-hydroxymethylcytosine in development and disease , 2012, Development.
[56] F. Coppedè,et al. Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. , 2012, Antioxidants & redox signaling.
[57] Hao Wu,et al. Regulation and function of mammalian DNA methylation patterns: a genomic perspective. , 2012, Briefings in functional genomics.
[58] I. Pérez-Otaño,et al. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease , 2012, Hippocampus.
[59] P. Kenny,et al. MicroRNAs in neuronal function and dysfunction , 2012, Trends in Neurosciences.
[60] S. Hébert,et al. MicroRNAs in Alzheimer's disease , 2012, Neurobiology of Disease.
[61] G. Passarino,et al. Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity , 2012, Immunity & Ageing.
[62] C. Bountra,et al. Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.
[63] S. Gandy,et al. Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease , 2012, BMC Medicine.
[64] H. Manev,et al. Mitochondrial DNA: a blind spot in neuroepigenetics , 2012, Biomolecular concepts.
[65] K. Sutherland,et al. The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T‐cell lymphoma patients , 2012, American journal of hematology.
[66] Xiaozhong Peng,et al. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice , 2012, Neurobiology of Aging.
[67] Wei Chen,et al. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. , 2012, Toxicology letters.
[68] J. Kleinman,et al. DNA methylation signatures in development and aging of the human prefrontal cortex. , 2012, American journal of human genetics.
[69] E. Junn,et al. MicroRNAs in neurodegenerative diseases and their therapeutic potential. , 2012, Pharmacology & therapeutics.
[70] G. Rabinovich,et al. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression , 2012, Journal of leukocyte biology.
[71] L. Tan,et al. The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy , 2012, Molecular Neurobiology.
[72] L. Martin,et al. Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.
[73] P. Falkai,et al. microRNA‐34c is a novel target to treat dementias , 2011, The EMBO journal.
[74] T. Maeda,et al. Effect of Vitamin E Administration on the Elevated Oxygen Stress and the Telomeric and Subtelomeric Status in Alzheimer’s Disease , 2011, Gerontology.
[75] A. Baccarelli,et al. DNA methylation in repetitive elements and Alzheimer disease , 2011, Brain, Behavior, and Immunity.
[76] Michael J Owen,et al. Alzheimer's disease genetics: current knowledge and future challenges , 2011, International journal of geriatric psychiatry.
[77] P. Nelson,et al. Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease , 2011, PloS one.
[78] R. Stilling,et al. The role of histone acetylation in age-associated memory impairment and Alzheimer’s disease , 2011, Neurobiology of Learning and Memory.
[79] J. Rogers,et al. Epigenetic mechanisms in Alzheimer's disease , 2011, Neurobiology of Aging.
[80] David M Holtzman,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[81] J. David Sweatt,et al. Epigenetic Mechanisms in Cognition , 2011, Neuron.
[82] X. Gidrol,et al. Pre-microRNA and Mature microRNA in Human Mitochondria , 2011, PloS one.
[83] D. Hwang,et al. Shot-gun proteomic analysis of mitochondrial D-loop DNA binding proteins: identification of mitochondrial histones. , 2011, Molecular bioSystems.
[84] Albert Hofman,et al. Plasma clusterin and the risk of Alzheimer disease. , 2011, JAMA.
[85] S. Philipsen,et al. Functional and sequence analysis of human neuroglobin gene promoter region. , 2011, Biochimica et biophysica acta.
[86] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[87] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[88] Shirley M. Taylor,et al. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria , 2011, Proceedings of the National Academy of Sciences.
[89] P. Jin,et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.
[90] L. Tsai,et al. Targeting the correct HDAC(s) to treat cognitive disorders. , 2010, Trends in pharmacological sciences.
[91] Joseph Rogers,et al. Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation , 2010, Neurobiology of Aging.
[92] B. Winblad,et al. A DNA Methylation Study of the Amyloid Precursor Protein Gene in Several Brain Regions from Patients with Familial Alzheimer Disease , 2010, Journal of neurogenetics.
[93] B. Doble,et al. Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci* , 2010, The Journal of Biological Chemistry.
[94] Peter A. Jones,et al. Epigenetic Modifications as Therapeutic Targets , 2010, Nature Biotechnology.
[95] P. Marks. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs , 2010, Expert opinion on investigational drugs.
[96] Francesca Tuorto,et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. , 2010, Genes & development.
[97] Susan M Resnick,et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.
[98] T. Preiss,et al. Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.
[99] A. Marini,et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons , 2010, Annals of the New York Academy of Sciences.
[100] S. Stahl. Fooling Mother Nature: Epigenetics and Novel Treatments for Psychiatric Disorders , 2010, CNS Spectrums.
[101] T. Suuronen,et al. Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease , 2010, Neuroscience Letters.
[102] Lennart Opitz,et al. Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.
[103] Z. Weng,et al. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex , 2010, Proceedings of the National Academy of Sciences.
[104] S. Stahl. Methylated Spirits: Epigenetic Hypotheses of Psychiatric Disorders , 2010, CNS Spectrums.
[105] M. Tsuda,et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. , 2010, Biochemical and biophysical research communications.
[106] Courtney A Miller,et al. Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.
[107] M. Fasshauer,et al. Amyloid precursor protein expression is induced by tumor necrosis factor α in 3T3‐L1 adipocytes , 2009, Journal of cellular biochemistry.
[108] Lucinda K. Southworth,et al. Aging Mice Show a Decreasing Correlation of Gene Expression within Genetic Modules , 2009, PLoS genetics.
[109] A. Fischer,et al. The epigenetic bottleneck of neurodegenerative and psychiatric diseases , 2009, Biological chemistry.
[110] M. Barrachina,et al. DNA Methylation of Alzheimer Disease and Tauopathy-Related Genes in Postmortem Brain , 2009, Journal of neuropathology and experimental neurology.
[111] F. Coppedè,et al. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. , 2009, Mutation research.
[112] Yu-hsuan Chen,et al. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. , 2009, Neurotoxicology.
[113] W-S Xu,et al. Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.
[114] B. Ray,et al. The “LEARn” (Latent Early-life Associated Regulation) model may explain the etiology of sporadic cases of Alzheimer's disease , 2009, Alzheimer's & Dementia.
[115] N. Heintz,et al. The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.
[116] M Schwaiger,et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.
[117] A. García-Osta,et al. Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model , 2009, Neuropsychopharmacology.
[118] F. Pasquier,et al. Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer’s disease? , 2009, Neuroscience Letters.
[119] Kunlin Chen,et al. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. , 2009, Biochemical and biophysical research communications.
[120] A. Guimarães,et al. Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[121] F. Sun,et al. Caspase inhibition attenuates accumulation of β-amyloid by reducing β-secretase production and activity in rat brains after stroke , 2008, Neurobiology of Disease.
[122] Hong Qing,et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.
[123] F. LaFerla,et al. Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau , 2008, The Journal of Neuroscience.
[124] Dao-Wen Wang,et al. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus , 2008, Neurobiology of Aging.
[125] Ming Wang,et al. S-adenosyl-L-methionine improves impaired hippocampal long-term potentiation and water maze performance induced by developmental lead exposure in rats. , 2008, European journal of pharmacology.
[126] M. Tsao,et al. Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma—Epigenetic downregulation of caspases , 2008, International journal of cancer.
[127] T. Tammela,et al. Clusterin is epigenetically regulated in prostate cancer , 2008, International journal of cancer.
[128] P. Dolan,et al. Histone deacetylase 6 interacts with the microtubule‐associated protein tau , 2008, Journal of neurochemistry.
[129] H. Tanila,et al. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A , 2008, Neurobiology of Disease.
[130] A. Wilson. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. , 2008, Journal of periodontology.
[131] Sun-Chong Wang,et al. Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.
[132] A. Bird,et al. DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.
[133] Jan-Gowth Chang,et al. A pilot study for circadian gene disturbance in dementia patients , 2008, Neuroscience Letters.
[134] F. D’Anselmi,et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.
[135] K. Jin,et al. Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo , 2007, Proceedings of the National Academy of Sciences.
[136] Dong Hou Kim,et al. Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. , 2007, Biochemical and biophysical research communications.
[137] W. Sippl,et al. Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins) , 2007, ChemMedChem.
[138] K. Engeland,et al. Cell cycle‐dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements , 2007, The FEBS journal.
[139] R. Jaenisch,et al. DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.
[140] Joel M Stein,et al. Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.
[141] T. Suuronen,et al. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. , 2007, Biochemical and biophysical research communications.
[142] R. Diaz-Arrastia,et al. Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation , 2007, The Journal of Neuroscience.
[143] W. Jagust,et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. , 2007, The American journal of clinical nutrition.
[144] J. Jolles,et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial , 2007, The Lancet.
[145] F. D’Anselmi,et al. Corrigendum to “S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production” [Mol. Cell. Neurosci. 28 (2005) 195–204] , 2006, Molecular and Cellular Neuroscience.
[146] A. Levey,et al. The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments , 2006, The Journal of Neuroscience.
[147] U. Werneke,et al. Complementary medicines in psychiatry , 2006, British Journal of Psychiatry.
[148] S. Kyrylenko,et al. Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells , 2005, Neurochemistry International.
[149] W. Markesbery,et al. Ribosome Dysfunction Is an Early Event in Alzheimer's Disease , 2005, The Journal of Neuroscience.
[150] Woo Ho Kim,et al. Loss of caspase-1 gene expression in human gastric carcinomas and cell lines. , 2005, International journal of oncology.
[151] E. Bertini,et al. Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients , 2005, European Journal of Human Genetics.
[152] F. D’Anselmi,et al. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.
[153] F. Liu,et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. , 2004, Biochemistry.
[154] C. Fuke,et al. Age Related Changes in 5‐methylcytosine Content in Human Peripheral Leukocytes and Placentas: an HPLC‐based Study , 2004, Annals of human genetics.
[155] Jorge Cortes,et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. , 2004, Blood.
[156] E. Masliah,et al. Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function , 2004, Journal of Neural Transmission.
[157] Raphael Kopan. Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. , 2003 .
[158] Andrea Fuso,et al. Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? , 2003, FEBS letters.
[159] Stuart L Schreiber,et al. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[160] I. Grundke‐Iqbal,et al. Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[161] H. Tohgi,et al. The methylation status of cytosines in a τ gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex , 1999, Neuroscience Letters.
[162] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[163] H. Tohgi,et al. Reduction with age in methylcytosine in the promoter region −224∼−101 of the amyloid precursor protein gene in autopsy human cortex , 1999 .
[164] Peter A. Jones,et al. The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.
[165] E. Mandelkow,et al. Tau in Alzheimer's disease. , 1998, Trends in cell biology.
[166] T. Suuronen,et al. Neuronal apoptosis induced by histone deacetylase inhibitors. , 1998, Brain research. Molecular brain research.
[167] S. Lovestone,et al. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. , 1997, Neuroscience.
[168] K. Bélanger,et al. Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer. , 1997, Anti-cancer drugs.
[169] S. Kish,et al. Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease , 1996, Journal of neurochemistry.
[170] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[171] B. Toone,et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[172] V. Wilson,et al. Genomic 5-methyldeoxycytidine decreases with age. , 1987, The Journal of biological chemistry.
[173] S. Goldstein,et al. Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. , 1983, The Journal of biological chemistry.
[174] A. Riggs,et al. DNA methylation and gene function. , 1980, Science.
[175] B. F. Vaniushin,et al. [DNA-methylase activities from animal mitochondria and nuclei: different specificity of DNA methylation]. , 1976, Biokhimiia.
[176] M. M. Nass. Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells. In vivo and in vitro methylation. , 1973, Journal of molecular biology.
[177] C. Rollán. Epigenetics: An overview , 2014 .
[178] Samira Lakhal,et al. RNAi Therapeutic Delivery by Exosomes , 2013 .
[179] Howard Hu,et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.
[180] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[181] A. Fuso,et al. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. , 2010, Journal of Alzheimer's disease : JAD.
[182] T. Groen. DNA Methylation and Alzheimer’s Disease , 2010 .
[183] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[184] F. Pasquier,et al. Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease , 2009, Molecular Psychiatry.
[185] P. Bertolucci,et al. Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.
[186] R. Obeid,et al. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases , 2007, Clinical chemistry and laboratory medicine.
[187] I. Pogribny,et al. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. , 2003, Carcinogenesis.
[188] I. Pogribny,et al. Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. , 2002, Carcinogenesis.
[189] M. Béné,et al. CSF-folate levels are decreased in late-onset AD patients , 2001, Journal of Neural Transmission.
[190] V. Klimenko,et al. The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents. , 1973, Gerontologia.
[191] V. Klimenko,et al. The 5-Methylcytosine in DNA of Rats , 1973 .